Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Amortizatization of Intangibles (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $800000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 29.87% to $800000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.1 million, a 120.8% increase, with the full-year FY2025 number at $3.1 million, up 106.67% from a year prior.
  • Amortizatization of Intangibles was $800000.0 for Q4 2025 at Day One Biopharmaceuticals, roughly flat from $800000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $800000.0 in Q2 2025 to a low of -$599000.0 in Q2 2023.
  • A 4-year average of $321714.3 and a median of $364000.0 in 2022 define the central range for Amortizatization of Intangibles.
  • Biggest YoY gain for Amortizatization of Intangibles was 1174.47% in 2023; the steepest drop was 571.65% in 2023.
  • Day One Biopharmaceuticals' Amortizatization of Intangibles stood at -$303000.0 in 2022, then crashed by 97.69% to -$599000.0 in 2023, then surged by 202.84% to $616000.0 in 2024, then rose by 29.87% to $800000.0 in 2025.
  • Per Business Quant, the three most recent readings for DAWN's Amortizatization of Intangibles are $800000.0 (Q4 2025), $800000.0 (Q3 2025), and $800000.0 (Q2 2025).